Mediart Lifesciences Private Limited, a active private limited company, was established on 21 October 2015 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51109DL2015PTC286671. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 71 professional, Its leadership includes Rajesh Kaul (Director), Ruby Gogia (Director). Past directors included Anu Bhatia, Amit Bhatia, Rachna Tandon. It holds ₹4.06 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 14/10, 1St Floor,, East Patel Nagar,, New Delhi, Delhi, 110008.
U51109DL2015PTC286671
286671
21 October 2015
₹1.00 Cr
₹1.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Mediart Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Kaul | Director | 21 Oct 2015 | Current |
| Ruby Gogia | Director | 03 Sep 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Dec 2018 | Past |
| Pramod Abcsdd | Director | 03 Sep 2016 | Past |
| Pramod Abcsdd | Director | 02 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mediart Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 29.8% increase. The company also saw a slight improvement in profitability, with a 6.53% increase in profit. The company's net worth Soared by an impressive increase of 10.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Mediart Lifesciences had a public holding of 58.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹40,600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2020 | Hdfc Bank Limited | ₹4.06 Cr | Open |
Explore comprehensive loan charge details -
Mediart Lifesciences has a workforce of 71 employees as of Dec 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mediart Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediart Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Mediart Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Mediart Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
Progress on A charge with Hdfc Bank Limited of Rs. 4.06 Cr registered on 26 Aug 2020 with Charge ID 100366915 was modified on 28 Jun 2024. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 4.06 Cr with Charge ID 100366915 was registered on 26 Aug 2020. was completed.
Progress on Ruby Gogia was appointed as a Director was appointed as a Director on 03 Sep 2016 & has been associated with this company since 9 years 3 months . was documented.
Progress on Rajesh Kaul was appointed as a Director was appointed as a Director on 21 Oct 2015 & has been associated with this company since 10 years 1 month . was documented.
The CIN of Mediart Lifesciences Private Limited is U51109DL2015PTC286671.
Mediart Lifesciences Private Limited is headquartered at 14/10, 1St Floor,, East Patel Nagar,, New Delhi, Delhi, 110008.
Mediart Lifesciences Private Limited was incorporated on 21 October 2015.
The current directors of Mediart Lifesciences Private Limited are
The primary industry of Mediart Lifesciences Private Limited is Trade.
Mediart Lifesciences Private Limited is unlisted.
The authorized capital of Mediart Lifesciences Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Mediart Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX